The mission of the Division of Hematology and Oncology at The Ohio State University is to continue as a national leader in the field of hematology and oncology while developing a molecular approach to medicine for the 21st century. This is being accomplished by striving toward excellence in the areas of patient care, research and teaching.

This divisional mission is supported and confirmed by the mission of The James Cancer Hospital which states:

The Comprehensive Cancer Center-Arthur G. James Cancer Hospital and Richard J. Solove Research Institute is a national and international leader in research, providing high quality patient care and educational programs for the benefit of the citizens of Ohio and beyond.

Through its highly qualified faculty and staff and their inter-disciplinary activities, the cancer program is uniquely positioned to reduce morbidity from cancer by:

• Conducting basic and clinical research
• Facilitating and expediting the transfer of results from scientific investigation to quality patient care
• Providing high quality health services in detection, diagnosis, treatment and rehabilitation
• Contributing to the educational advancement of health professionals
• Increasing public awareness regarding cancer
• Promoting public policy changes to improve prevention, detection and treatment of cancer

The cancer program and other units of The Ohio State University work in partnership with other research centers, institutional providers of health services and health professionals to reduce the incidence of cancer and to provide effective treatment for patients with cancer.